TFG
Basic information
Region (hg38): 3:100709295-100748964
Links
Phenotypes
GenCC
Source:
- hereditary motor and sensory neuropathy, Okinawa type (Supportive), mode of inheritance: AD
- hereditary spastic paraplegia 57 (Supportive), mode of inheritance: AR
- autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation (Supportive), mode of inheritance: AD
- hereditary motor and sensory neuropathy, Okinawa type (Strong), mode of inheritance: AD
- hereditary spastic paraplegia 57 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neuropathy, hereditary motor and sensory, Okinawa type; Spastic paraplegia 57 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal; Neurologic | 17906970; 22883144; 23479643; 23553329; 25098539 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 (2 variants)
- Hereditary spastic paraplegia 57 (1 variants)
- not provided (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TFG gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 79 | 84 | ||||
missense | 170 | 179 | ||||
nonsense | 6 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 7 | 17 | 4 | 28 | ||
non coding | 50 | 37 | 88 | |||
Total | 2 | 2 | 184 | 134 | 41 |
Highest pathogenic variant AF is 0.00000657
Variants in TFG
This is a list of pathogenic ClinVar variants found in the TFG region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-100709442-G-T | not specified | Benign (Apr 26, 2015) | ||
3-100709467-AT-A | Benign (Feb 20, 2020) | |||
3-100709512-A-G | Benign (Jun 16, 2021) | |||
3-100709616-G-C | Benign (Jun 20, 2018) | |||
3-100709800-T-C | Benign (Feb 21, 2020) | |||
3-100713482-A-G | Likely benign (Sep 18, 2018) | |||
3-100713570-CATCTA-C | Benign (Sep 30, 2021) | |||
3-100713641-AG-A | Uncertain significance (Jan 09, 2024) | |||
3-100713691-C-T | Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 | Likely benign (Aug 10, 2023) | ||
3-100713694-AC-GA | Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 | Uncertain significance (Feb 07, 2020) | ||
3-100713702-A-C | Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 | Uncertain significance (Nov 09, 2022) | ||
3-100713709-T-C | Hereditary spastic paraplegia 57;Hereditary motor and sensory neuropathy, Okinawa type | Likely benign (Apr 14, 2023) | ||
3-100713709-T-G | Uncertain significance (Jun 08, 2017) | |||
3-100713710-G-A | Hereditary spastic paraplegia 57;Hereditary motor and sensory neuropathy, Okinawa type | Uncertain significance (Sep 08, 2022) | ||
3-100713718-A-T | Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 | Likely benign (Apr 08, 2023) | ||
3-100713719-A-G | Hereditary spastic paraplegia 57;Hereditary motor and sensory neuropathy, Okinawa type • Inborn genetic diseases | Uncertain significance (Mar 05, 2020) | ||
3-100713722-A-G | Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 | Uncertain significance (May 30, 2022) | ||
3-100713738-G-C | Hereditary spastic paraplegia 57;Hereditary motor and sensory neuropathy, Okinawa type | Uncertain significance (May 18, 2022) | ||
3-100713742-G-A | Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 | Likely benign (Oct 14, 2021) | ||
3-100713746-A-G | Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 | Uncertain significance (Apr 25, 2023) | ||
3-100713746-A-T | Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 • Inborn genetic diseases | Uncertain significance (Jan 12, 2024) | ||
3-100713749-C-T | Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 | Pathogenic (Sep 19, 2022) | ||
3-100713753-G-A | Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 • Inborn genetic diseases | Uncertain significance (Jan 23, 2024) | ||
3-100713753-G-T | Uncertain significance (Sep 16, 2019) | |||
3-100713765-A-G | Hereditary motor and sensory neuropathy, Okinawa type;Hereditary spastic paraplegia 57 | Uncertain significance (Jul 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TFG | protein_coding | protein_coding | ENST00000240851 | 7 | 39606 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.141 | 0.859 | 125739 | 0 | 8 | 125747 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.33 | 166 | 222 | 0.748 | 0.0000115 | 2579 |
Missense in Polyphen | 21 | 41.309 | 0.50837 | 530 | ||
Synonymous | -1.09 | 87 | 75.0 | 1.16 | 0.00000372 | 796 |
Loss of Function | 3.31 | 6 | 23.2 | 0.259 | 0.00000130 | 233 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000292 | 0.0000292 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000533 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000336 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in the normal dynamic function of the endoplasmic reticulum (ER) and its associated microtubules (PubMed:23479643, PubMed:27813252). {ECO:0000269|PubMed:23479643, ECO:0000269|PubMed:27813252}.;
- Disease
- DISEASE: Neuropathy, hereditary motor and sensory, Okinawa type (HMSNO) [MIM:604484]: A neurodegenerative disorder characterized by young adult onset of proximal muscle weakness and atrophy, muscle cramps, and fasciculations, with later onset of distal sensory impairment. The disorder is slowly progressive and clinically resembles amyotrophic lateral sclerosis. {ECO:0000269|PubMed:22883144, ECO:0000269|PubMed:27813252}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spastic paraplegia 57, autosomal recessive (SPG57) [MIM:615658]: A complicated form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. Complicated forms are recognized by additional variable features including spastic quadriparesis, seizures, dementia, amyotrophy, extrapyramidal disturbance, cerebral or cerebellar atrophy, optic atrophy, and peripheral neuropathy, as well as by extra neurological manifestations. {ECO:0000269|PubMed:23479643, ECO:0000269|PubMed:27492651, ECO:0000269|PubMed:27813252}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Pathways in cancer - Homo sapiens (human);Thyroid cancer - Homo sapiens (human);Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;EGFR1;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport
(Consensus)
Recessive Scores
- pRec
- 0.247
Intolerance Scores
- loftool
- 0.391
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.32
Haploinsufficiency Scores
- pHI
- 0.154
- hipred
- Y
- hipred_score
- 0.654
- ghis
- 0.594
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.859
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tfg
- Phenotype
Gene ontology
- Biological process
- endoplasmic reticulum to Golgi vesicle-mediated transport;positive regulation of I-kappaB kinase/NF-kappaB signaling;COPII vesicle coating
- Cellular component
- Golgi membrane;cytoplasm;cytosol;endoplasmic reticulum exit site
- Molecular function
- protein binding;identical protein binding